Get started
Author

Jacob Skilling

Global real-world patients characteristics, treatment patterns, and impact of BCG shortage in patients with high-risk non-muscle invasive bladder cancer.
2025 · Jens Bedke, Anthony Eccleston, et al. · Journal of Clinical Oncology · 7
Embedding genetic testing in the metastatic prostate cancer pathway: understanding patient and physician perspectives
2025 · Ruhee Jain, Amanda Ribbands, et al. · Future Oncology · 1
PDF
Patient perception of high-risk non-muscle-invasive bladder cancer
2026 · Andrea Kokorovic, Wassim Kassouf, et al. · Canadian Urological Association Journal
PDF
Real‐world radical cystectomy use in high‐risk non‐muscle‐invasive bladder cancer: a global survey
2026 · Jose Luis Dominguez Escrig, Peter Black, et al. · British Journal of Urology
PDF
Evolution of treatment distribution and patient characteristics of muscle invasive bladder cancer patients: results from two multi-national real-world surveys
2026 · Miraj Y. Patel, Xingzhi Wang, et al. · BMC Urology
Management of high-risk non-muscle invasive bladder cancer: a real-world study in North America, Europe and Japan
2026 · Jens Bedke, Anthony Eccleston, et al. · Figshare
Management of high-risk non-muscle invasive bladder cancer: a real-world study in North America, Europe and Japan
2026 · Jens Bedke, Anthony Eccleston, et al. · Future Oncology
PDF
RWD24 Association of Recurrences With Healthcare Resource Utilization in High-Risk Non-Muscle Invasive Bladder Cancer Patients Across Europe: A Real-World Survey
2025 · Siobhán Mulhern-Haughey, Farah Hodeib, et al. · Value in Health
Global real-world use of radical cystectomy in patients with high-risk non–muscle invasive bladder cancer
2025 · J.L. Dominguez-Escrig, P. Black, et al. · European Urology Open Science
Health-related quality of life in muscle invasive bladder cancer patients receiving radical surgery versus those who do not: A real-world survey
2025 · J.W.F. Catto, F. Hodeib, et al. · European Urology Open Science
3119eP Real-world use of Bacillus Calmette Guérin (BCG) in patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC)
2025 · G. Pignot, W. Kassouf, et al. · Annals of Oncology
RWD12 Patient-Reported Symptoms and Quality of Life: A Real-World Survey of Patients With Muscle Invasive Bladder Cancer
2025 · Jens Bedke, Anthony Eccleston, et al. · Value in Health
RWD152 Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
2025 · Jens Bedke, Anthony Eccleston, et al. · Value in Health
P099 – Treatment patterns in muscle invasive bladder cancer patients across Europe and the United Kingdom: A real-world survey
2025 · M. Roumiguie, F. Hodeib, et al. · European Urology
Homologous recombination repair mutation testing patterns in metastatic castration-resistant prostate cancer: Analysis of real-world data in the United States.
2025 · Pedro C. Barata, Suvina Amin, et al. · Journal of Clinical Oncology
PDF
Treatment patterns of MIBC patients not receiving radical cystectomy: Results from a real-world survey in Europe.
2025 · Anthony Eccleston, Abin Koshy, et al. · Journal of Clinical Oncology
P250 Treatment patterns in treatment naïve high-risk non-muscle invasive bladder cancer across EU4 + UK: A real-world study
2024 · G. Simone, S. Darbas, et al. · European Urology Open Science
Homologous recombination repair mutation (HRRm) testing patterns among men with metastatic castration-resistant prostate cancer (mCRPC): Interim results from a real-world (rw) study in Europe
2023 · E. Castro, A. Niyazov, et al. · European Urology Open Science
Combined chemoradiation (CRT) with high dose rate brachytherapy (HDR) for locally advanced cervical cancer: A regional experience
2005 · A. Lin, J. Ryu, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 8
H-index: 1
I10-index:
Year
Topic
Type